TWC
GSK icon

TD Waterhouse Canada’s GSK GSK Stock Holding History

TD Waterhouse Canada’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
32,957
+12,229
+59% +$663K 0.01% 571
2025
Q4 		$1.02M Buy
20,728
+245
+1% +$11.4K 0.01% 561
2025
Q3 		$932K Sell
20,483
-195
-0.9% -$7.62K 0.01% 569
2025
Q2 		$805K Sell
20,678
-127
-0.6% -$4.85K 0.01% 572
2025
Q1 		$788K Sell
20,805
-158
-0.8% -$5.78K 0.01% 565
2024
Q4 		$709K Buy
20,963
+1,332
+7% +$48K 0.01% 562
2024
Q3 		$791K Buy
19,631
+1,779
+10% +$72.8K 0.01% 538
2024
Q2 		$686K Buy
17,852
+81
+0.5% +$3.41K 0.01% 547
2024
Q1 		$776K Sell
17,771
-616
-3% -$25.4K 0.01% 546
2023
Q4 		$750K Buy
18,387
+374
+2% +$13.4K 0.01% 465
2023
Q3 		$680K Sell
18,013
-805
-4% -$28.6K 0.01% 476
2023
Q2 		$681K Buy
18,818
+1,522
+9% +$54.6K 0.01% 478
2023
Q1 		$638K Buy
17,296
+242
+1% +$8.47K 0.01% 489
2022
Q4 		$617K Sell
17,054
-1,542
-8% -$51.4K 0.01% 488
2022
Q3 		$571K Buy
18,596
+785
+4% +$29.8K 0.01% 483
2022
Q2 		$1M Sell
17,811
-3,030
-15% -$167K 0.01% 411
2022
Q1 		$1.15M Sell
20,841
-44,133
-68% -$2.4M 0.01% 423
2021
Q4 		$3.57M Buy
+64,974
New +$3.38M 0.03% 267

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TD Waterhouse Canada's GSK Position: Q1 2026 in Review

TD Waterhouse Canada increased its GSK (GSK) stake by 59% in Q1 2026, buying an estimated $663K and bringing the position to 32,957 shares worth $1.85M. The position accounts for 0.01% of the portfolio, ranked #571.

TD Waterhouse Canada first reported a position in GSK in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.57M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • TD Waterhouse Canada held 32,957 shares of GSK worth $1.85M as of Q1 2026.
  • TD Waterhouse Canada bought 12,229 GSK shares in Q1 2026, an estimated $663K.
  • GSK made up 0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #571 holding.
  • TD Waterhouse Canada first reported a position in GSK in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's GSK position peaked at $3.57M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.